<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19543522</article-id>
      <article-id pub-id-type="pmc">2698205</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2009.24.3.525</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Kyung Min</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoon</surname>
            <given-names>Dok Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Seung Geun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Sung Nam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sug</surname>
            <given-names>Lyu Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huh</surname>
            <given-names>Jooryung</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Suh</surname>
            <given-names>Cheolwon</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Address for correspondence: Cheolwon Suh, M.D. Department of Internal Medicine, Asan Medical Center, 388-1 Pungnap 2-dong, Songpa-gu, Seoul 138-736, Korea. Tel: +82.2-3010-3209, Fax: +82.2-3010-6961, <email>csuh@amc.seoul.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>6</month>
        <year>2009</year>
      </pub-date>
      <volume>24</volume>
      <issue>3</issue>
      <fpage>525</fpage>
      <lpage>528</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>6</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2009 The Korean Academy of Medical Sciences</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Primary adrenal lymphoma is a very rare extranodal lymphoma; its clinical features consist of a high incidence of bilateral adrenal involvement and diffuse large B-cell lymphoma. We report a patient with primary bilateral adrenal diffuse large B-cell lyphoma who achieved complete remission with R-CHOP (rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy. A 52-yr-old man presented with fever and progressive fatigue for 3 months. Computed tomography (CT) scans of the abdomen and pelvis demonstrated large bilateral adrenal masses, and a needle biopsy of the left adrenal mass revealed diffuse large B-cell lymphoma. After 6 cycles of R-CHOP chemotherapy, CT scans showed no residual disease. To our knowledge, this is the second report to date of a patient with primary bilateral adrenal diffuse large B-cell lymphoma who achieved complete remission using R-CHOP chemotherapy.</p>
      </abstract>
      <kwd-group>
        <kwd>Primary Adrenal Lymphoma</kwd>
        <kwd>Lymphoma, Large B-Cell, Diffuse</kwd>
        <kwd>R-CHOP</kwd>
        <kwd>Complete Remission</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Although secondary involvement of the adrenal gland has been reported to occur in up to 25% of patients with non-Hodgkin's lymphoma (NHL) (<xref ref-type="bibr" rid="B1">1</xref>), primary adrenal lymphoma (PAL) is very rare, with only about 80 cases reported in the English language literature (<xref ref-type="bibr" rid="B2">2</xref>). Treatment of PAL is similar to that of other types of lymphoma, but prognosis is poor. Therapeutic modalities include surgery, combination chemotherapy, and/or radiotherapy. Among the chemotherapy regimens utilized are CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), CVP (cyclophosphamide, vincristine, and prednisone), and MACOP-B (adding methotrexate and bleomycin) (<xref ref-type="bibr" rid="B2">2</xref>). Here, we describe a patient with primary bilateral adrenal diffuse large B-cell lymphoma who achieved complete remission after treatment with rituximab plus CHOP (R-CHOP).</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A 52-yr-old man with no prior medical history was admitted for a 3-month history of fever and progressive fatigue. He appeared chronically ill, but alert. Blood pressure was 100/70 mmHg, pulse rate was 102 bpm, respiratory rate was 22 bpm, and body temperature was 38.5&#x2103;. Examination of head and neck was unremarkable; no abnormality was found in chest; no hepatosplenomegaly or mass was detected in the abdomen; and there was no evidence of lymphadenopathy or abnormal skin lesions.</p>
      <p>A complete blood count showed hemoglobin 10.4 g/dL, hematocrit 30.0%, white blood cell count 5,000/&#xB5;L, and platelet count 104,000/&#xB5;L. Sodium level was 126 mM/L (normal range, 133-150 mM/L), but potassium and calcium levels were normal. Serum &#x3B2;<sup>2</sup>-microglobulin concentration was 4.7 &#xB5;g/mL (normal range, 1-2.4 &#xB5;g/mL), serum lactate dehydrogenase (LDH) level was 476 IU/L (normal range, 120-250 IU/L), serum cortisol concentration at 8 AM was 2.9 &#xB5;g/dL (normal range, 7-25 &#xB5;g/dL), plasma ACTH level at 8 AM was 210 pg/mL (normal range, 9-52 pg/mL), and serum aldosterone concentration was 56.2 pg/mL (normal range, 20-160 pg/mL). Urinalysis showed that 24 hr excretion of vanillylmandelic acid was 5.9 mg/day (normal range, 0-8 mg/day), of epinephrine was 21.5 &#xB5;g/day (normal range, 0-20 &#xB5;g/day), of norepinephrine was 202.1 &#xB5;g/day (normal range, 1-130 &#xB5;g/day), and of total metanephrine was 0.6 mg/day (normal range 0-1.3 mg/day). Rapid cosyntropin (analog of ACTH) stimulation test, using 250 &#xB5;g of intravenous cosyntropin, demonstrated plasma cortisol concentrations at 0, 30 and 60 min of 9.5, 10.0 and 10.5 &#xB5;g/dL, respectively (reference range, at least 7 &#xB5;g/dL at 0 min, 16 &#xB5;g/dL at 30 min, and 18 &#xB5;g/dL at 60 min), strongly suggesting adrenal insufficiency.</p>
      <p>Chest radiography was normal without evidence of hilar lymphadenopathy. Computed tomography (CT) scans of abdomen and pelvis demonstrated large bilateral adrenal masses. The right adrenal gland measured 5.8&#xD7;2.7 cm, and the left adrenal gland measured 3.7&#xD7;2.0 cm in its greatest dimension (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
      <p>A CT-guided core needle biopsy of the left adrenal mass was performed. The tumor was comprised of large cells, which were immunohistochemically positive for CD20, but negative for CD3 and CD30. The Ki-67 labeling index was about 90%. The tumor was diagnosed as a diffuse large B-cell lymphoma (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      <p>Bone marrow biopsy was negative for lymphomatous involvement. An F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) scan showed intense FDG accumulation in both adrenal glands. There was no abnormal FDG uptake in the rest of the body (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
      <p>The patient was administered adrenal hormone replacement therapy with 20 mg hydrocortisone at 8 AM and 10 mg at 4 PM. He was also administered R-CHOP chemotherapy, consisting of rituximab (375 mg/m<sup>2</sup> i.v.), cyclophosphamide (750 mg/m<sup>2</sup> i.v.), doxorubicin (50 mg/m<sup>2</sup> i.v.), and vincristine (1.4 mg/m<sup>2</sup> i.v.), on day 1, and prednisolone (100 mg p.o.) on days 1-5, every 3 weeks. After completing 6 cycles of R-CHOP chemotherapy, there was no evidence of tumor on follow-up CT and FDG-PET scans (<xref ref-type="fig" rid="F4">Fig. 4</xref>). To date, this patient has been followed regularly at our outpatient clinic for the past 12 months, with no evidence of tumor recurrence.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>PAL is a very rare lymphoma, with only about 80 cases reported in the English language literature (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Histologically, the most common type is diffuse large B-cell lymphoma, with most originating in both adrenal glands (<xref ref-type="table" rid="T1">Table 1</xref>). PAL is most common in elderly men; the mean age at diagnosis is 68 yr and the male-to-female ratio is 2.2:1. Clinical symptoms of PAL include fever, weight loss, local pain, and symptoms of adrenal insufficiency (<xref ref-type="bibr" rid="B8">8</xref>). Immune dysfunction may be a predisposing factor in some patients (<xref ref-type="bibr" rid="B3">3</xref>). A review of 55 PAL patients showed that 8 (15%) had a concurrent or past history of carcinoma, 2 (4%) had human immunodeficiency virus (HIV) infection, and 7 (13%) had concomitant autoimmune disease (<xref ref-type="bibr" rid="B8">8</xref>).</p>
      <p>On CT and magnetic resonance imaging (MRI), PALs tend to appear as complex masses of variable density and often have areas of necrosis and/or hemorrhage, with most tumors being bilateral (<xref ref-type="bibr" rid="B8">8</xref>). Because most PAL patients have adrenal involvement only, without any nodal involvement, whole body FDG-PET, which measures increased glucose metabolism and has been used in tumor diagnosis and staging, in monitoring response to treatment, and detecting recurrence, has shown intense FDG uptake only in the adrenal glands (<xref ref-type="bibr" rid="B2">2</xref>). In our patient, whole-body FDG-PET demonstrated FDG uptake in the adrenal masses, with no evidence of abnormal uptake in extraadrenal regions.</p>
      <p>Tissue samples can be obtained by CT- or ultrasound-guided biopsy or by surgical excisional biopsy (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Histologically, the most common type of PAL is diffuse large B-cell lymphoma (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B8">8</xref>). These neoplastic cells express antigens specific to B lymphocytes, such as CD20, CD74, CDw75, and CD79a, while not expressing antigens specific to T lymphocytes, such as CD3, CD5, CD43, and CD45RO (<xref ref-type="bibr" rid="B26">26</xref>).</p>
      <p>Because of the rarity of PAL, therapeutic regimens have not been defined in detail (<xref ref-type="bibr" rid="B2">2</xref>), with most patients treated with regimens similar to those used to treat other types of lymphoma. Therapeutic modalities include surgery, combination chemotherapy, and radiation (<xref ref-type="bibr" rid="B8">8</xref>). Most patients with PAL have been treated with CHOP and the remainder with CVP or MACOP-B (<xref ref-type="bibr" rid="B2">2</xref>). The roles of radiation therapy and surgical excision of the adrenal glands in the context of bilateral involvement are not known (<xref ref-type="bibr" rid="B3">3</xref>). The prognosis of patients with PAL is very poor, with uncertain duration of survival (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Poor prognosis is thought to be due to advanced age at diagnosis, large tumor size, increased LDH level, bilateral adrenal involvement (regarded as stage IV disease), and adrenal insufficiency at the time of presentation, indicating extensive adrenal destruction (<xref ref-type="bibr" rid="B3">3</xref>).</p>
      <p>The most common regimen of PAL is CHOP, with a 71-yr-old man with primary bilateral adrenal diffuse large B-cell lymphoma reported to have continued in complete remission for 7 yr after treatment with the CHOP regimen (<xref ref-type="bibr" rid="B18">18</xref>). Recent evidence suggests that the outcome of elderly patients with diffuse large B-cell lymphoma is improved by the addition of rituximab to CHOP (<xref ref-type="bibr" rid="B28">28</xref>). Our patient, who was administered 6 cycles of R-CHOP every 3 weeks, showed complete remission on follow-up CT and FDG-PET. Although a 62-yr-old man with primary bilateral diffuse large B-cell lymphoma who was treated with a left adrenalectomy, R-CHOP, radiotherapy, and high-dose chemotherapy with autologous peripheral blood stem cell transplantation, has been disease-free for 2 yr, this report was in Japanese (<xref ref-type="bibr" rid="B29">29</xref>). Moreover, in contrast to this patient, our patient received only R-CHOP chemotherapy, without surgery, radiation or high-dose therapy.</p>
      <p>In conclusion, this may be the second report of a patient with primary bilateral adrenal diffuse large B-cell lymphoma who achieved complete remission using R-CHOP chemotherapy.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Jaslowitz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Craver</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Lymphosarcoma: a review of 1269 cases</article-title>
          <source>Medicine (Baltimore)</source>
          <year>1961</year>
          <volume>40</volume>
          <fpage>31</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">13743408</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Xiu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mavi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El-Haddad</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Alavi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature</article-title>
          <source>Clin Nucl Med</source>
          <year>2005</year>
          <volume>30</volume>
          <fpage>222</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="pmid">15764875</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grigg</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Connors</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma</article-title>
          <source>Clin Lymphoma</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>154</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">14715097</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Utsunomiya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takatera</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsujimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Itatani</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Bilateral primary non-Hodgkin's lymphoma of the adrenal glands with adrenal insufficiency: a case report</article-title>
          <source>Hinyokika Kiyo</source>
          <year>1992</year>
          <volume>38</volume>
          <fpage>311</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">1523986</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Itami</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shiina</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uno</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arimizu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mikata</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tamaru</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>MR imaging of primary adrenal lymphoma</article-title>
          <source>Clin Imaging</source>
          <year>1996</year>
          <volume>20</volume>
          <fpage>126</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="pmid">8744822</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Fiar</surname>
              <given-names>FZ</given-names>
            </name>
            <name>
              <surname>Pantalony</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Primary bilateral adrenal lymphoma</article-title>
          <source>Leuk Lymphoma</source>
          <year>1997</year>
          <volume>27</volume>
          <fpage>543</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="pmid">9477138</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nasu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aruga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itami</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Non-Hodgkin's lymphoma presenting with adrenal insufficiency and hypothyroidism: an autopsy case report</article-title>
          <source>Pathol Int</source>
          <year>1998</year>
          <volume>48</volume>
          <fpage>138</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">9589478</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Renslo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Tabbarah</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Barajas</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>French</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Clinically silent primary adrenal lymphoma: a case report and review of the literature</article-title>
          <source>Am J Hematol</source>
          <year>1998</year>
          <volume>58</volume>
          <fpage>130</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">9625581</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sheu</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Harn</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>TY</given-names>
            </name>
          </person-group>
          <article-title>Adrenal insufficiency caused by primary aggressive non-Hodgkin's lymphoma of bilateral adrenal glands: report of a case and literature review</article-title>
          <source>Ann Hematol</source>
          <year>1999</year>
          <volume>78</volume>
          <fpage>151</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="pmid">10211758</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salvatore</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Primary bilateral adrenal lymphoma</article-title>
          <source>Leuk Lymphoma</source>
          <year>1999</year>
          <volume>34</volume>
          <fpage>111</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">10350338</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fearon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rahilly</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal B cell lymphoma</article-title>
          <source>Hosp Med</source>
          <year>1999</year>
          <volume>60</volume>
          <fpage>759</fpage>
          <lpage>760</lpage>
          <pub-id pub-id-type="pmid">10656073</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ozaki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kimoto</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Primary bilateral adrenal lymphoma associated with idiopathic thrombocytopenic purpura</article-title>
          <source>Leuk Lymphoma</source>
          <year>1999</year>
          <volume>35</volume>
          <fpage>403</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="pmid">10706466</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuyama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Munemasa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsutsui</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Aga</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kanetada</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Successful treatment of primary adrenal non-Hodgkin's lymphoma associated with adrenal insufficiency</article-title>
          <source>Leuk Lymphoma</source>
          <year>2000</year>
          <volume>38</volume>
          <fpage>203</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="pmid">10811465</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clemens</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Pins</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>NonHodgkin's lymphoma presenting as bilateral testicular and adrenal masses</article-title>
          <source>J Urol</source>
          <year>2000</year>
          <volume>163</volume>
          <fpage>241</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">10604363</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsunaga</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Motoyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ga-67 and I-131 adosterol scintigraphic findings of bilateral primary adrenal lymphoma</article-title>
          <source>Clin Nucl Med</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>718</fpage>
          <lpage>720</lpage>
          <pub-id pub-id-type="pmid">10983762</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamashita</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Primary bilateral adrenal involvement of non-Hodgkin's lymphoma shown on a Ga-67 citrate scan</article-title>
          <source>Clin Nucl Med</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>721</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="pmid">10983763</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viswanathan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Middleton</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma: a case report</article-title>
          <source>Clin Nucl Med</source>
          <year>2001</year>
          <volume>26</volume>
          <fpage>787</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="pmid">11507302</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schocket</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Syed</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Fine</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma with choroidal metastases</article-title>
          <source>Am J Ophthalmol</source>
          <year>2002</year>
          <volume>134</volume>
          <fpage>775</fpage>
          <lpage>776</lpage>
          <pub-id pub-id-type="pmid">12429262</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hahn</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Suh</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>A case of primary bilateral adrenal lymphoma (PAL) with central nervous system (CNS) involvement</article-title>
          <source>Yonsei Med J</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>385</fpage>
          <lpage>390</lpage>
          <pub-id pub-id-type="pmid">12089750</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YL</given-names>
            </name>
          </person-group>
          <article-title>Adrenal lymphoma and Addison's disease: report of a case</article-title>
          <source>J Formos Med Assoc</source>
          <year>2002</year>
          <volume>101</volume>
          <fpage>854</fpage>
          <lpage>858</lpage>
          <pub-id pub-id-type="pmid">12632819</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma</article-title>
          <source>Leuk Lymphoma</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>739</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">12769357</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Won</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma manifestating as adrenal incidentaloma</article-title>
          <source>J Chin Med Assoc</source>
          <year>2003</year>
          <volume>66</volume>
          <fpage>67</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">12728978</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillett</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haak</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Not just another fall in the elderly. Bilateral adrenal lymphoma presenting with adrenal insufficiency causing weakness</article-title>
          <source>Aust Fam Physician</source>
          <year>2003</year>
          <volume>32</volume>
          <fpage>248</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">12735264</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Petit</surname>
              <given-names>W</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Bernene</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma presenting as adrenal insufficiency. A case report and review of literature</article-title>
          <source>Conn Med</source>
          <year>2004</year>
          <volume>68</volume>
          <fpage>7</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">14752912</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vijayaraghavan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thulkar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tandon</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Adrenal involvement in non-Hodgkin's lymphoma: four cases and review of literature</article-title>
          <source>Leuk Lymphoma</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>789</fpage>
          <lpage>794</lpage>
          <pub-id pub-id-type="pmid">15160957</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Libe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Giavoli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Barbetta</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dall'Asta</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Passini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buffa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beck-Peccoz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ambrosi</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A primary adrenal non-Hodgkin's lymphoma presenting as an incidental adrenal mass</article-title>
          <source>Exp Clin Endocrinol Diabetes</source>
          <year>2006</year>
          <volume>114</volume>
          <fpage>140</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">16636981</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Airaghi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Carrabba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barcella</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baldini</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Bonara</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Goldaniga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baldini</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Unusual presentation of large B cell lymphoma: a case report and review of literature</article-title>
          <source>Clin Lab Haematol</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>338</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">16999726</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coiffier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lepage</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Briere</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Herbrecht</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tilly</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bouabdallah</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Van Den Neste</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Salles</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gaulard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Reyes</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lederlin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gisselbrecht</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>346</volume>
          <fpage>235</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">11807147</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shirao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsunaga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Niitsu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Konuma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hirayama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kohda</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Effective combined modality therapy for a patient with primary adrenal lymphoma</article-title>
          <source>Rinsho Ketsueki</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>204</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">16629485</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Abdominal pelvic CT scan showing bilateral adrenal masses.</p>
      </caption>
      <graphic xlink:href="jkms-24-525-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>CT-guided core needle biopsy of the left adrenal mass showing a tumor comprised of large cells, immunohistochemically positive for CD20 but negative for CD3 and CD30. The Ki-67 labeling index was about 90%. The tumor was diagnosed as a diffuse large B-cell lymphoma.</p>
      </caption>
      <graphic xlink:href="jkms-24-525-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) scan showing intense FDG accumulation in both adrenal glands. There was no abnormal FDG uptake in the rest of the body.</p>
      </caption>
      <graphic xlink:href="jkms-24-525-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Fig. 4</label>
      <caption>
        <p>Follow-up CT and FDG-PET scans after 6 cycles of R-CHOP chemotherapy showing no evidence of tumor.</p>
      </caption>
      <graphic xlink:href="jkms-24-525-g004"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>List of documented cases of primary bilateral adrenal diffuse large B-cell lymphoma in the English language literature</p>
      </caption>
      <graphic xlink:href="jkms-24-525-i001"/>
      <table-wrap-foot>
        <fn>
          <p>A, adriamycin; B, bleomycin; B/L, bilateral; C, cyclophosphamide; CR, complete remission; D, dexamethasone; E, epirubicin; Et, etoposide; FUO, fever of unknown origin; H, doxorubicin; IT, intrathecal; L, left; M, mitozantrone; Met, metastasis; MTX, methotrexate; mo, month; NM, not mentioned; NS, not specified; O, vincristine; P, prednisolone; R, right; Wt, weight.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
